BIVI: BioVie Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 28.23
Enterprise Value ($M) 11.52
Book Value ($M) 14.07
Book Value / Share 1.55
Price / Book 2.01
NCAV ($M) 12.98
NCAV / Share 1.43
Price / NCAV 2.17

Profitability (mra)
Return on Invested Capital (ROIC) -1.44
Return on Assets (ROA) -1.08
Return on Equity (ROE) -3.39

Liquidity (mrq)
Quick Ratio 2.95
Current Ratio 2.95

Balance Sheet (mrq) ($M)
Current Assets 20.15
Assets 21.24
Liabilities 7.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -32.18
Net Income -32.12
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -27.95
Cash from Investing 14.53
Cash from Financing 17.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
10-25 13G 3i, LP 7.60
06-25 13D/A Acuitas Group Holdings, LLC 44.53 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-09-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED JUNE 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SEC
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One)
2024-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 795,769 2,058,815 38.65
2024-11-21 1,225,850 3,108,846 39.43
2024-11-20 558,691 1,469,922 38.01
2024-11-19 1,251,430 3,420,300 36.59
2024-11-18 1,094,968 2,710,400 40.40

(click for more detail)

Similar Companies
BFRG – Bullfrog AI Holdings, Inc. BFRI – Biofrontera Inc.
BGM – BGM Group Ltd BMRA – Biomerica, Inc.
BNTC – Benitec Biopharma Inc.


Financial data and stock pages provided by
Fintel.io